Jupiter Asset Management LTD Vanda Pharmaceuticals Inc. Transaction History

Jupiter Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$9.31 - $11.84 $189,877 - $241,476	-20,395 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$10.84 - $16.55 $14,634 - $22,342	-1,350 Reduced 6.21%	20,395 $230,000
Q4 2021 Feb 11, 2022	BUY	$15.69 - $21.14 $109,720 - $147,832	6,993 Added 47.4%	21,745 $341,000
Q3 2021 Nov 10, 2021	BUY	$15.35 - $21.27 $20,722 - $28,714	1,350 Added 10.07%	14,752 $253,000
Q1 2021 May 12, 2021	SELL	$13.42 - $20.28 $173,426 - $262,078	-12,923 Reduced 49.09%	13,402 $201,000
Q4 2020 Feb 10, 2021	BUY	$9.77 - $13.81 $257,195 - $363,548	26,325 New	26,325 $346,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.